These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 16122429)
1. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Tsuda H; Jafar-Nejad H; Patel AJ; Sun Y; Chen HK; Rose MF; Venken KJ; Botas J; Orr HT; Bellen HJ; Zoghbi HY Cell; 2005 Aug; 122(4):633-44. PubMed ID: 16122429 [TBL] [Abstract][Full Text] [Related]
2. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707 [TBL] [Abstract][Full Text] [Related]
3. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Cummings CJ; Orr HT; Zoghbi HY Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309 [TBL] [Abstract][Full Text] [Related]
4. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model. Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130 [TBL] [Abstract][Full Text] [Related]
5. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722 [TBL] [Abstract][Full Text] [Related]
6. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Hong S; Kim SJ; Ka S; Choi I; Kang S Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161 [TBL] [Abstract][Full Text] [Related]
7. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986 [TBL] [Abstract][Full Text] [Related]
8. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse. Wang HL; Hu SH; Chou AH; Wang SS; Weng YH; Yeh TH Neuropharmacology; 2013 Jul; 70():1-11. PubMed ID: 23347954 [TBL] [Abstract][Full Text] [Related]
9. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice. Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814 [TBL] [Abstract][Full Text] [Related]
10. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. Mizutani A; Wang L; Rajan H; Vig PJ; Alaynick WA; Thaler JP; Tsai CC EMBO J; 2005 Sep; 24(18):3339-51. PubMed ID: 16121196 [TBL] [Abstract][Full Text] [Related]
11. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product. Hong S; Ka S; Kim S; Park Y; Kang S Biochim Biophys Acta; 2003 May; 1638(1):35-42. PubMed ID: 12757932 [TBL] [Abstract][Full Text] [Related]
12. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195 [TBL] [Abstract][Full Text] [Related]
13. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1. Ju H; Kokubu H; Lim J Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589 [TBL] [Abstract][Full Text] [Related]
14. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; Pérez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871 [TBL] [Abstract][Full Text] [Related]